Mitsuo Sawai
Chief Executive Officer chez SAWAI GROUP HOLDINGS CO., LTD.
Fortune : 42 M $ au 31/03/2024
Profil
Mitsuo Sawai is currently the Chairman & Group Chief Executive Officer at SAWAI GROUP HOLDINGS Co., Ltd.
He also holds the position of Chairman at Sawai Pharmaceutical Co., Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/09/2023 | 1 057 000 ( 2,41% ) | 42 M $ | 31/03/2024 |
Postes actifs de Mitsuo Sawai
| Sociétés | Poste | Début |
|---|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Chief Executive Officer | 01/04/2021 |
Sawai Pharmaceutical Co., Ltd.
 Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Chairman | 23/06/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SAWAI GROUP HOLDINGS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Sawai Pharmaceutical Co., Ltd.
Sawai Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. It operates through the Japan and United States segments. The Japan segment sells manufactured pharmaceuticals to domestic sales companies, wholesale stores and other pharmaceutical manufacturers, as well as directly to medical institutions. The United States segment comprises of holding companies that manages subsidiaries and sell manufactured pharmaceuticals to wholesale stores in the United States. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. | Health Technology |
